Skip to main content
. 2023 Dec 12;57(Suppl 1):209–217. doi: 10.1007/s43465-023-01049-4

Table 1.

Summary of effect of glucose-lowering therapies on bone

Drug Effect on bone Comments
(1) Insulin Anabolic to bone Increased risk of falls due to hypoglycemia. Increased fracture risk could be a confounding effect of long disease duration, poor glycemic control and chronic complications
(2) Insulin secretagogues Neutral May increase risk of falls by causing hypoglycemia
(3) Metformin Neutral or slightly positive
(4) Thiazolidinediones Decrease BMD Increase bone marrow adipogenesis and decrease osteoblastic differentiation
(5) GLP-1 agonists Neutral or favourable
(6) Dipeptidyl peptidase 4 (DPP4) inhibitors Neutral or favourable
(7) SGLT2 inhibitors Increased fracture risk Data are mainly with canagliflozin